These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 32960871)

  • 1. Table: Inhibitors and inducers of CYP enzymes and P-glycoprotein.
    Med Lett Drugs Ther; 2020 Sep; 62(1607):e152-e153. PubMed ID: 32960871
    [No Abstract]   [Full Text] [Related]  

  • 2. Table: Inhibitors and inducers of CYP enzymes, P-glycoprotein, and other transporters.
    Med Lett Drugs Ther; 2023 Feb; 65(1669):e28-e30. PubMed ID: 36757353
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibitors and inducers of CYP enzymes and P-Glycoprotein.
    Med Lett Drugs Ther; 2016 Mar; 58(1491):e46-7. PubMed ID: 27027691
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluation of the impact of cantharidin on rat CYP enzymes by using a cocktail of probe drugs.
    Zhou CJ; Qiao LM; Zhao LH; Li ZY
    Fitoterapia; 2015 Dec; 107():49-53. PubMed ID: 26498206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Translational aspects of cytochrome P450-mediated drug-drug interactions: A case study with clopidogrel.
    Tornio A; Filppula AM; Backman JT
    Basic Clin Pharmacol Toxicol; 2022 Jan; 130 Suppl 1():48-59. PubMed ID: 34410044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P-Glycoprotein in clinical cardiology.
    Rodriguez I; Abernethy DR; Woosley RL
    Circulation; 1999 Feb; 99(4):472-4. PubMed ID: 9927391
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibitors and inducers of CYP enzymes and P-glycoprotein.
    Med Lett Drugs Ther; 2017 Mar; 59(1517):e56. PubMed ID: 28323813
    [No Abstract]   [Full Text] [Related]  

  • 8. Variability of Voriconazole Trough Levels in Haematological Patients: Influence of Comedications with cytochrome P450(CYP) Inhibitors and/or with CYP Inhibitors plus CYP Inducers.
    Cojutti P; Candoni A; Forghieri F; Isola M; Zannier ME; Bigliardi S; Luppi M; Fanin R; Pea F
    Basic Clin Pharmacol Toxicol; 2016 Jun; 118(6):474-9. PubMed ID: 26572687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory and inductive effects of Phikud Navakot extract on human cytochrome P450.
    Chiangsom A; Lawanprasert S; Oda S; Kulthong K; Luechapudiporn R; Yokoi T; Maniratanachote R
    Drug Metab Pharmacokinet; 2016 Jun; 31(3):210-7. PubMed ID: 27212065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the in vitro and in vivo metabolic pathway and cytochrome P450 inhibition/induction profile of Huperzine A.
    Lin PP; Li XN; Yuan F; Chen WL; Yang MJ; Xu HR
    Biochem Biophys Res Commun; 2016 Nov; 480(2):248-253. PubMed ID: 27751854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytochrome P450 time-dependent inhibition and induction: advances in assays, risk analysis and modelling.
    Riley RJ; Wilson CE
    Expert Opin Drug Metab Toxicol; 2015 Apr; 11(4):557-72. PubMed ID: 25659570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous and comprehensive in vivo analysis of cytochrome P450 activity by using a cocktail approach in rats.
    Uchida S; Tanaka S; Namiki N
    Biopharm Drug Dispos; 2014 May; 35(4):228-36. PubMed ID: 24395703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drugs as CYP3A probes, inducers, and inhibitors.
    Liu YT; Hao HP; Liu CX; Wang GJ; Xie HG
    Drug Metab Rev; 2007; 39(4):699-721. PubMed ID: 18058330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preliminary in Vitro Assessment of the Potential of EST64454, a Sigma-1 Receptor Antagonist, for Pharmacokinetic Drug-Drug Interactions.
    Yeste S; Reinoso RF; Ayet E; Pretel MJ; Balada A; Serafini MT
    Biol Pharm Bull; 2020; 43(1):68-76. PubMed ID: 31902934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methadone Metabolism and Drug-Drug Interactions: In Vitro and In Vivo Literature Review.
    Volpe DA; Xu Y; Sahajwalla CG; Younis IR; Patel V
    J Pharm Sci; 2018 Dec; 107(12):2983-2991. PubMed ID: 30205091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of kanglaite on rat cytochrome P450.
    Du X; Ye H; Zhang C; Ye L; Lin G
    Pharm Biol; 2015 Jul; 53(7):995-1001. PubMed ID: 25472767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Baoyuan decoction, a traditional Chinese medicine formula, on the activities and mRNA expression of seven CYP isozymes in rats.
    Lu YY; Du ZY; Li Y; Wang JL; Zhao MB; Jiang Y; Guo XY; Tu PF
    J Ethnopharmacol; 2018 Oct; 225():327-335. PubMed ID: 30048731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory effects of CYP3A4 substrates and their metabolites on P-glycoprotein-mediated transport.
    Katoh M; Nakajima M; Yamazaki H; Yokoi T
    Eur J Pharm Sci; 2001 Feb; 12(4):505-13. PubMed ID: 11231118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erectile Dysfunction Drugs Changed the Protein Expressions and Activities of Drug-Metabolising Enzymes in the Liver of Male Rats.
    Sheweita SA; Wally M; Hassan M
    Oxid Med Cell Longev; 2016; 2016():4970906. PubMed ID: 27800121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the antioxidant baicalein on the pharmacokinetics of nimodipine in rats: a possible role of P-glycoprotein and CYP3A4 inhibition by baicalein.
    Cho YA; Choi JS; Burm JP
    Pharmacol Rep; 2011; 63(4):1066-73. PubMed ID: 22001996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.